Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy.

Authors :: Harrysson S
Eloranta S
Ekberg S
Enblad G
Andersson PO
Sonnevi K
Ljungqvist M
Sander B
Jerkeman M
Smedby KE
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2024 Apr; Vol. 65 (4), pp. 534-537. Date of Electronic Publication: 2023 Dec 22.
Publication Year :: 2024

Subjects :: Humans
Immunotherapy, Adoptive adverse effects
Antigens, CD19
Lymphoma, Large B-Cell, Diffuse pathology
Lymphoma, Non-Hodgkin etiology

Full Text Access

Tools